TreeWAS – Variant ID: rs150934526

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.007	0.993	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.005	0.995	0.000
H04.1 Other disorders of lachrymal gland	0.004	0.996	0.000
K26 Duodenal ulcer	0.004	0.996	0.000
H04 Disorders of lachrymal system	0.004	0.996	0.000
K02.9 Dental caries, unspecified	0.004	0.996	0.000
K26.7 Chronic without haemorrhage or perforation	0.004	0.996	0.000
C44.6 Skin of upper limb, including shoulder	0.000	0.996	0.004
C61 Malignant neoplasm of prostate	0.000	0.996	0.004
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.996	0.004
K26.3 Acute without haemorrhage or perforation	0.004	0.996	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.003	0.997	0.000
K26.5 Chronic or unspecified with perforation	0.003	0.997	0.000
K26.4 Chronic or unspecified with haemorrhage	0.003	0.997	0.000
K26.2 Acute with both haemorrhage and perforation	0.003	0.997	0.000
K26.1 Acute with perforation	0.003	0.997	0.000
K26.0 Acute with haemorrhage	0.003	0.997	0.000
H04.9 Disorder of lachrymal system, unspecified	0.003	0.997	0.000
H04.8 Other disorders of lachrymal system	0.003	0.997	0.000
H04.6 Other changes in lachrymal passages	0.003	0.997	0.000
H04.4 Chronic inflammation of lachrymal passages	0.003	0.997	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.003	0.997	0.000
H04.0 Dacryoadenitis	0.003	0.997	0.000
C44.7 Skin of lower limb, including hip	0.000	0.997	0.003
C44.5 Skin of trunk	0.000	0.997	0.003
K02 Dental caries	0.003	0.997	0.000
H04.2 Epiphora	0.003	0.997	0.000
C44 Other malignant neoplasms of skin	0.000	0.997	0.003
H35.3 Degeneration of macula and posterior pole	0.003	0.997	0.000
D70 Agranulocytosis	0.003	0.997	0.000
Z51.1 Chemotherapy session for neoplasm	0.003	0.997	0.000
J44 Other chronic obstructive pulmonary disease	0.000	0.997	0.003
C44.4 Skin of scalp and neck	0.000	0.998	0.002
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.002	0.998	0.000
H02 Other disorders of eyelid	0.002	0.998	0.000
J18.1 Lobar pneumonia, unspecified	0.000	0.998	0.002
H02.8 Other specified disorders of eyelid	0.002	0.998	0.000
K02.8 Other dental caries	0.002	0.998	0.000
K02.5 Caries with pulp exposure	0.002	0.998	0.000
K02.4 Odontoclasia	0.002	0.998	0.000
K02.3 Arrested dental caries	0.002	0.998	0.000
K02.2 Caries of cementum	0.002	0.998	0.000
K02.1 Caries of dentin	0.002	0.998	0.000
K02.0 Caries limited to enamel	0.002	0.998	0.000
W19.9 Unspecified place	0.002	0.998	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.998	0.002
C44.8 Overlapping lesion of skin	0.000	0.998	0.002
H02.6 Xanthelasma of eyelid	0.002	0.998	0.000
J47 Bronchiectasis	0.000	0.998	0.002
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.998	0.002
M16.1 Other primary coxarthrosis	0.000	0.998	0.002
H02.5 Other disorders affecting eyelid function	0.002	0.998	0.000
K22.7 Barrett's oesophagus	0.000	0.998	0.002
H02.0 Entropion and trichiasis of eyelid	0.002	0.998	0.000
H35 Other retinal disorders	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
H35.8 Other specified retinal disorders	0.002	0.998	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.002	0.998	0.000
H05 Disorders of orbit	0.002	0.998	0.000
H03 Disorders of eyelid in diseases classified elsewhere	0.002	0.998	0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.002	0.998	0.000
H02.7 Other degenerative disorders of eyelid and periocular area	0.002	0.998	0.000
H02.2 Lagophthalmos	0.002	0.998	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.000	0.998	0.002
K08 Other disorders of teeth and supporting structures	0.002	0.998	0.000
H02.9 Disorder of eyelid, unspecified	0.002	0.998	0.000
H02.3 Blepharochalasis	0.002	0.998	0.000
J40-J47 Chronic lower respiratory diseases	0.000	0.998	0.002
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.998	0.002
H00 Hordeolum and chalazion	0.002	0.998	0.000
C44.0 Skin of lip	0.000	0.998	0.002
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.998	0.002
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.002	0.998	0.000
C43.5 Malignant melanoma of trunk	0.000	0.998	0.002
C44.1 Skin of eyelid, including canthus	0.000	0.998	0.002
J45 Asthma	0.000	0.998	0.002
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
H35.9 Retinal disorder, unspecified	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.002	0.998	0.000
H35.6 Retinal haemorrhage	0.002	0.998	0.000
H35.5 Hereditary retinal dystrophy	0.002	0.998	0.000
H35.4 Peripheral retinal degeneration	0.002	0.998	0.000
H35.2 Other proliferative retinopathy	0.002	0.998	0.000
H35.1 Retinopathy of prematurity	0.002	0.998	0.000
H35.0 Background retinopathy and retinal vascular changes	0.002	0.998	0.000
H01 Other inflammation of eyelid	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
K08.3 Retained dental root	0.002	0.998	0.000
K09 Cysts of oral region, not elsewhere classified	0.002	0.998	0.000
H02.1 Ectropion of eyelid	0.002	0.998	0.000
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.002	0.998	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.002	0.998	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.002	0.998	0.000
H05.9 Disorder of orbit, unspecified	0.002	0.998	0.000
H05.8 Other disorders of orbit	0.002	0.998	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.002	0.998	0.000
H05.4 Enophthalmos	0.002	0.998	0.000
H05.3 Deformity of orbit	0.002	0.998	0.000
H05.2 Exophthalmic conditions	0.002	0.998	0.000
H05.1 Chronic inflammatory disorders of orbit	0.002	0.998	0.000
H05.0 Acute inflammation of orbit	0.002	0.998	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.2 Dysthyroid exophthalmos	0.002	0.998	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.002	0.998	0.000
K12 Stomatitis and related lesions	0.002	0.998	0.000
M47.86 Other spondylosis (Lumbar region)	0.002	0.998	0.000
H02.4 Ptosis of eyelid	0.002	0.998	0.000
K08.8 Other specified disorders of teeth and supporting structures	0.002	0.998	0.000
K06 Other disorders of gingiva and edentulous alveolar ridge	0.002	0.998	0.000
K04 Diseases of pulp and periapical tissues	0.002	0.998	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.002	0.998	0.000
K08.2 Atrophy of edentulous alveolar ridge	0.002	0.998	0.000
K08.0 Exfoliation of teeth due to systemic causes	0.002	0.998	0.000
C60-C63 Malignant neoplasms of male genital organs	0.000	0.998	0.002
B25.9 Cytomegaloviral disease, unspecified	0.002	0.998	0.000
Y60.4 During endoscopic examination	0.002	0.998	0.000
Z71.8 Other specified counselling	0.002	0.998	0.000
J41 Simple and mucopurulent chronic bronchitis	0.000	0.998	0.002
J42 Unspecified chronic bronchitis	0.000	0.998	0.002
J45.0 Predominantly allergic asthma	0.000	0.998	0.002
K22.8 Other specified diseases of oesophagus	0.000	0.998	0.002
K09.0 Developmental odontogenic cysts	0.002	0.998	0.000
K12.3 Oral mucositis (ulcerative)	0.002	0.998	0.000
J40 Bronchitis, not specified as acute or chronic	0.000	0.998	0.002
K04.5 Chronic apical periodontitis	0.002	0.998	0.000
K10 Other diseases of jaws	0.002	0.998	0.000
K03 Other diseases of hard tissues of teeth	0.002	0.998	0.000
K00 Disorders of tooth development and eruption	0.002	0.998	0.000
C44.2 Skin of ear and external auricular canal	0.001	0.998	0.001
K11 Diseases of salivary glands	0.002	0.998	0.000
K07 Dentofacial anomalies [including malocclusion]	0.002	0.998	0.000
C44.3 Skin of other and unspecified parts of face	0.000	0.998	0.002
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.001	0.998	0.000
J46 Status asthmaticus	0.000	0.998	0.001
D03.3 Melanoma in situ of other and unspecified parts of face	0.002	0.998	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.001	0.998	0.000
K05 Gingivitis and periodontal diseases	0.001	0.998	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.998	0.002
H01.9 Inflammation of eyelid, unspecified	0.001	0.998	0.000
H01.8 Other specified inflammation of eyelid	0.001	0.998	0.000
H01.1 Non-infectious dermatoses of eyelid	0.001	0.998	0.000
J45.8 Mixed asthma	0.000	0.998	0.001
J45.1 Nonallergic asthma	0.000	0.998	0.001
C43 Malignant melanoma of skin	0.000	0.998	0.001
K13.0 Diseases of lips	0.001	0.998	0.000
J43 Emphysema	0.000	0.998	0.001
K13 Other diseases of lip and oral mucosa	0.002	0.998	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.001	0.998	0.000
J45.9 Asthma, unspecified	0.000	0.998	0.002
K09.9 Cyst of oral region, unspecified	0.001	0.998	0.000
K09.8 Other cysts of oral region, not elsewhere classified	0.001	0.998	0.000
K09.2 Other cysts of jaw	0.001	0.998	0.000
K09.1 Developmental (nonodontogenic) cysts of oral region	0.001	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.001	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.998	0.000
Y43.4 Immunosuppressive agents	0.001	0.998	0.000
Y43.2 Antineoplastic natural products	0.001	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.001	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.001	0.998	0.000
K12.2 Cellulitis and abscess of mouth	0.001	0.998	0.000
K12.0 Recurrent oral aphthae	0.001	0.998	0.000
W19 Unspecified fall	0.001	0.998	0.000
K04.6 Periapical abscess with sinus	0.001	0.998	0.000
K04.4 Acute apical periodontitis of pulpal origin	0.001	0.998	0.000
K04.3 Abnormal hard tissue formation in pulp	0.001	0.998	0.000
K04.2 Pulp degeneration	0.001	0.998	0.000
K04.1 Necrosis of pulp	0.001	0.998	0.000
K04.0 Pulpitis	0.001	0.998	0.000
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified	0.001	0.998	0.000
K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma	0.001	0.998	0.000
K06.1 Gingival enlargement	0.001	0.998	0.000
K06.0 Gingival recession	0.001	0.998	0.000
W29.9 Unspecified place	0.001	0.998	0.000
Y60.0 During surgical operation	0.001	0.998	0.000
K14 Diseases of tongue	0.001	0.998	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.998	0.001
J41.1 Mucopurulent chronic bronchitis	0.000	0.998	0.001
J41.0 Simple chronic bronchitis	0.000	0.998	0.001
K04.7 Periapical abscess without sinus	0.001	0.998	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.000	0.998	0.001
C62 Malignant neoplasm of testis	0.000	0.998	0.001
C60 Malignant neoplasm of penis	0.000	0.998	0.001
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.998	0.000
K12.1 Other forms of stomatitis	0.001	0.999	0.000
Y52 Agents primarily affecting the cardiovascular system	0.001	0.999	0.000
K00.9 Disorder of tooth development, unspecified	0.001	0.999	0.000
K00.8 Other disorders of tooth development	0.001	0.999	0.000
K00.7 Teething syndrome	0.001	0.999	0.000
K00.6 Disturbances in tooth eruption	0.001	0.999	0.000
K00.5 Hereditary disturbances in tooth structure, not elsewhere classified	0.001	0.999	0.000
K00.4 Disturbances in tooth formation	0.001	0.999	0.000
K00.3 Mottled teeth	0.001	0.999	0.000
K00.2 Abnormalities of size and form of teeth	0.001	0.999	0.000
K00.1 Supernumerary teeth	0.001	0.999	0.000
K00.0 Anodontia	0.001	0.999	0.000
K03.9 Disease of hard tissues of teeth, unspecified	0.001	0.999	0.000
K03.8 Other specified diseases of hard tissues of teeth	0.001	0.999	0.000
K03.7 Posteruptive colour changes of dental hard tissues	0.001	0.999	0.000
K03.6 Deposits [accretions] on teeth	0.001	0.999	0.000
K03.5 Ankylosis of teeth	0.001	0.999	0.000
K03.4 Hypercementosis	0.001	0.999	0.000
K03.3 Pathological resorption of teeth	0.001	0.999	0.000
K03.2 Erosion of teeth	0.001	0.999	0.000
K03.1 Abrasion of teeth	0.001	0.999	0.000
K03.0 Excessive attrition of teeth	0.001	0.999	0.000
K10.9 Disease of jaws, unspecified	0.001	0.999	0.000
K10.8 Other specified diseases of jaws	0.001	0.999	0.000
K10.3 Alveolitis of jaws	0.001	0.999	0.000
K10.2 Inflammatory conditions of jaws	0.001	0.999	0.000
K10.1 Giant cell granuloma, central	0.001	0.999	0.000
K10.0 Developmental disorders of jaws	0.001	0.999	0.000
K11.9 Disease of salivary gland, unspecified	0.001	0.999	0.000
K11.8 Other diseases of salivary glands	0.001	0.999	0.000
K11.7 Disturbances of salivary secretion	0.001	0.999	0.000
K11.6 Mucocele of salivary gland	0.001	0.999	0.000
K11.5 Sialolithiasis	0.001	0.999	0.000
K11.4 Fistula of salivary gland	0.001	0.999	0.000
K11.3 Abscess of salivary gland	0.001	0.999	0.000
K11.1 Hypertrophy of salivary gland	0.001	0.999	0.000
K11.0 Atrophy of salivary gland	0.001	0.999	0.000
K07.9 Dentofacial anomaly, unspecified	0.001	0.999	0.000
K07.8 Other dentofacial anomalies	0.001	0.999	0.000
K07.5 Dentofacial functional abnormalities	0.001	0.999	0.000
K07.4 Malocclusion, unspecified	0.001	0.999	0.000
K07.3 Anomalies of tooth position	0.001	0.999	0.000
K07.2 Anomalies of dental arch relationship	0.001	0.999	0.000
K07.1 Anomalies of jaw-cranial base relationship	0.001	0.999	0.000
K07.0 Major anomalies of jaw size	0.001	0.999	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.001	0.999	0.000
K11.2 Sialoadenitis	0.001	0.999	0.000
C43.9 Malignant melanoma of skin, unspecified	0.000	0.999	0.001
C43.8 Overlapping malignant melanoma of skin	0.000	0.999	0.001
C43.4 Malignant melanoma of scalp and neck	0.000	0.999	0.001
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.999	0.001
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.999	0.001
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.999	0.001
C43.0 Malignant melanoma of lip	0.000	0.999	0.001
H00.1 Chalazion	0.001	0.999	0.000
K05.2 Acute periodontitis	0.001	0.999	0.000
K05.6 Periodontal disease, unspecified	0.001	0.999	0.000
K05.5 Other periodontal diseases	0.001	0.999	0.000
K05.4 Periodontosis	0.001	0.999	0.000
K05.1 Chronic gingivitis	0.001	0.999	0.000
K05.0 Acute gingivitis	0.001	0.999	0.000
K07.6 Temporomandibular joint disorders	0.001	0.999	0.000
A41.9 Septicaemia, unspecified	0.001	0.999	0.000
J43.8 Other emphysema	0.000	0.999	0.001
J43.2 Centrilobular emphysema	0.000	0.999	0.001
J43.1 Panlobular emphysema	0.000	0.999	0.001
J43.0 MacLeod's syndrome	0.000	0.999	0.001
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.001	0.999	0.000
K13.6 Irritative hyperplasia of oral mucosa	0.001	0.999	0.000
K13.5 Oral submucous fibrosis	0.001	0.999	0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.001	0.999	0.000
K13.3 Hairy leukoplakia	0.001	0.999	0.000
K13.1 Cheek and lip biting	0.001	0.999	0.000
Y60.9 During unspecified surgical and medical care	0.001	0.999	0.000
Y60.8 During other surgical and medical care	0.001	0.999	0.000
Y60.7 During administration of enema	0.001	0.999	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.001	0.999	0.000
Y60.5 During heart catheterisation	0.001	0.999	0.000
Y60.3 During injection or immunisation	0.001	0.999	0.000
Y60.2 During kidney dialysis or other perfusion	0.001	0.999	0.000
Y60.1 During infusion or transfusion	0.001	0.999	0.000
Y40 Systemic antibiotics	0.001	0.999	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.999	0.001
W19.8 Other specified place	0.001	0.999	0.000
W19.5 Trade and service area	0.001	0.999	0.000
W19.0 Home	0.001	0.999	0.000
W19.7 Farm	0.001	0.999	0.000
W19.6 Industrial and construction area	0.001	0.999	0.000
W19.3 Sports and athletics area	0.001	0.999	0.000
W19.1 Residential institution	0.001	0.999	0.000
H01.0 Blepharitis	0.001	0.999	0.000
K14.9 Disease of tongue, unspecified	0.001	0.999	0.000
K14.6 Glossodynia	0.001	0.999	0.000
K14.5 Plicated tongue	0.001	0.999	0.000
K14.4 Atrophy of tongue papillae	0.001	0.999	0.000
K14.3 Hypertrophy of tongue papillae	0.001	0.999	0.000
K14.2 Median rhomboid glossitis	0.001	0.999	0.000
K14.1 Geographic tongue	0.001	0.999	0.000
K01 Embedded and impacted teeth	0.001	0.999	0.000
W29 Contact with other powered hand tools and household machinery	0.001	0.999	0.000
C16.0 Cardia	0.001	0.999	0.000
C60.9 Penis, unspecified	0.000	0.999	0.001
C60.8 Overlapping lesion of penis	0.000	0.999	0.001
C60.2 Body of penis	0.000	0.999	0.001
C60.1 Glans penis	0.000	0.999	0.001
C60.0 Prepuce	0.000	0.999	0.001
C62.9 Testis, unspecified	0.000	0.999	0.001
C62.1 Descended testis	0.000	0.999	0.001
C62.0 Undescended testis	0.000	0.999	0.001
C63.9 Male genital organ, unspecified	0.000	0.999	0.001
C63.8 Overlapping lesion of male genital organs	0.000	0.999	0.001
C63.7 Other specified male genital organs	0.000	0.999	0.001
C63.2 Scrotum	0.000	0.999	0.001
C63.1 Spermatic cord	0.000	0.999	0.001
C63.0 Epididymis	0.000	0.999	0.001
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
K04.8 Radicular cyst	0.001	0.999	0.000
K05.3 Chronic periodontitis	0.001	0.999	0.000
Y40.0 Penicillins	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
Y52.1 Calcium-channel blockers	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
K14.0 Glossitis	0.001	0.999	0.000
B25 Cytomegaloviral disease	0.001	0.999	0.000
S62.61 Fracture of other finger (open)	0.001	0.999	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.999	0.001
I73.9 Peripheral vascular disease, unspecified	0.001	0.999	0.000
Z71.9 Counselling, unspecified	0.001	0.999	0.000
Z71.3 Dietary counselling and surveillance	0.001	0.999	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.001	0.999	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
K05.22 Aggressive periodontitis, generalized	0.001	0.999	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.999	0.001
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
Y40.8 Other systemic antibiotics	0.001	0.999	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.5 Aminoglycosides	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y40.3 Macrolides	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.999	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.001	0.999	0.000
K13.29 Other disturbances of oral epithelium, including tongue	0.001	0.999	0.000
M16.9 Coxarthrosis, unspecified	0.000	0.999	0.001
N35.9 Urethral stricture, unspecified	0.000	0.999	0.001
M16 Coxarthrosis [arthrosis of hip]	0.000	0.999	0.001
W00-W19 Falls	0.001	0.999	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.001	0.999	0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.001	0.999	0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.001	0.999	0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.001	0.999	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.999	0.001
K01.0 Embedded teeth	0.001	0.999	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.001	0.999	0.000
N84.1 Polyp of cervix uteri	0.000	0.999	0.001
W29.8 Other specified place	0.001	0.999	0.000
W29.6 Industrial and construction area	0.001	0.999	0.000
W29.0 Home	0.001	0.999	0.000
W29.7 Farm	0.001	0.999	0.000
W29.5 Trade and service area	0.001	0.999	0.000
W29.4 Street and highway	0.001	0.999	0.000
W29.3 Sports and athletics area	0.001	0.999	0.000
W29.2 School, other institution and public administrative area	0.001	0.999	0.000
W29.1 Residential institution	0.001	0.999	0.000
Z45.2 Adjustment and management of vascular access device	0.001	0.999	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.001	0.999	0.000
K14.8 Other diseases of tongue	0.001	0.999	0.000
W19.2 School, other institution and public administrative area	0.001	0.999	0.000
W25.9 Unspecified place	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y41.0 Sulphonamides	0.001	0.999	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.999	0.000
Y44.7 Plasma substitutes	0.001	0.999	0.000
Y44.6 Natural blood and blood products	0.001	0.999	0.000
Y44.5 Thrombolytic drugs	0.001	0.999	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.999	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.999	0.000
Y44.2 Anticoagulants	0.001	0.999	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.999	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.999	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.999	0.000
Y47.4 Bromine compounds	0.001	0.999	0.000
Y47.3 Paraldehyde	0.001	0.999	0.000
Y47.2 Chloral derivatives	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
Y56.9 Topical agent, unspecified	0.001	0.999	0.000
Y56.8 Other topical agents	0.001	0.999	0.000
Y56.7 Dental drugs, topically applied	0.001	0.999	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.999	0.000
Y56.2 Local astringents and local detergents	0.001	0.999	0.000
Y56.1 Antipruritics	0.001	0.999	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
Y57.9 Drug or medicament, unspecified	0.001	0.999	0.000
Y57.8 Other drugs and medicaments	0.001	0.999	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.999	0.000
Y57.6 Other diagnostic agents	0.001	0.999	0.000
Y57.5 X-ray contrast media	0.001	0.999	0.000
Y57.4 Pharmaceutical excipients	0.001	0.999	0.000
Y57.3 Alcohol deterrents	0.001	0.999	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
Y57.1 Lipotropic drugs	0.001	0.999	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000
Y58.4 Tetanus vaccine	0.001	0.999	0.000
Y58.3 Plague vaccine	0.001	0.999	0.000
Y58.2 Cholera vaccine	0.001	0.999	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.999	0.000
Y58.0 BCG vaccine	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations